Capital Fund Management S.A. Akero Therapeutics, Inc. Transaction History

Capital Fund Management S.A.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$18.31 - $24.62 $67,820 - $91,192	-3,704 Reduced 17.37%	17,619 $413,000
Q1 2024 May 15, 2024	SELL	$17.76 - $31.18 $33,672 - $59,117	-1,896 Reduced 8.17%	21,323 $538,000
Q4 2023 Feb 14, 2024	BUY	$11.38 - $50.33 $264,232 - $1.17 Million	23,219 New	23,219 $542,000
Q1 2023 May 15, 2023	BUY	$37.27 - $50.24 $567,659 - $765,205	15,231 New	15,231 $582,000

190

73.8M

241K

647K

Ticker AKRO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,417,600
Market Cap $1.36B
Description
Akero Therapeutics, Inc., a cardio-metabolic nonalcoholic steatohepatitis (NASH) company, engages in the development of medicines designed to restore metabolic balance and improve overall health. The company's lead product candidate is efruxifermin (EFX), an analog of fibroblast growth factor 21, which protects against cellular stress and regula...

Get notified when there are updates to the investment portfolio of Capital Fund Management S.A., based on Form 13F filings with the SEC.

Stay updated on Capital Fund Management S.A. with notifications on news.